Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$490K
Filings
68
Firms Hired
5
Active Period
2005–2014
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
H.R. 4187, DISARM Act of 2014. S. 2236, Strategies to Address Antimicrobial Resistance (STARR) Act.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4187
Strategies to Address Antimicrobial Resistance Act
2014 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
H.R. 4187, DISARM Act of 2014. S. 2236, Strategies to Address Antimicrobial Resistance (STARR) Act.
Client expense: — · Firm income: $50,000
Matched citations: S. 2236
H.R. 4187, DISARM Act of 2014.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4187
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choices Act S.525/H.R.1298, The Pharmaceutical Market Access and Drug Safety Act of 2009.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1298
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choices Act Tax policy (repatriation). S.525/H.R.1298, The Pharmaceutical Market Access and Drug Safety Act of 2009.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1298
America's Affordable Health Choices Act of 2009
2009 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choices Act
Client expense: — · Firm income: $60,000
Matched citations: H.R.3200
America's Affordable Health Choices Act of 2009
2009 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choices Act Tax policy (repatriation). S.525/H.R.1298, The Pharmaceutical Market Access and Drug Safety Act of 2009.
Client expense: — · Firm income: $60,000
Matched citations: H.R.3200
America's Affordable Health Choices Act of 2009
2009 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choices Act S.525/H.R.1298, The Pharmaceutical Market Access and Drug Safety Act of 2009.
Client expense: — · Firm income: $60,000
Matched citations: H.R.3200
Affordable Health Choices Act
2009 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choices Act
Client expense: — · Firm income: $60,000
Matched citations: S.1679
Affordable Health Choices Act
2009 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choices Act S.525/H.R.1298, The Pharmaceutical Market Access and Drug Safety Act of 2009.
Client expense: — · Firm income: $60,000
Matched citations: S.1679
Affordable Health Choices Act
2009 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choices Act Tax policy (repatriation). S.525/H.R.1298, The Pharmaceutical Market Access and Drug Safety Act of 2009.
Client expense: — · Firm income: $60,000
Matched citations: S.1679
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choices Act Tax policy (repatriation). S.525/H.R.1298, The Pharmaceutical Market Access and Drug Safety Act of 2009.
Client expense: — · Firm income: $60,000
Matched citations: S.525
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate: H.R.3200, America's Affordable Health Choices Act and S.1679, Affordable Health Choices Act S.525/H.R.1298, The Pharmaceutical Market Access and Drug Safety Act of 2009.
Client expense: — · Firm income: $60,000
Matched citations: S.525
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate. Tax policy (repatriation). S.525/H.R.1298, The Pharmaceutical Market Access and Drug Safety Act of 2009.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1298
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate. S.525/H.R.1298, The Pharmaceutical Market Access and Drug Safety Act of 2009.
Client expense: — · Firm income: $60,000
Matched citations: H.R.1298
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate. S.525/H.R.1298, The Pharmaceutical Market Access and Drug Safety Act of 2009.
Client expense: — · Firm income: $60,000
Matched citations: S.525
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate. Tax policy (repatriation). S.525/H.R.1298, The Pharmaceutical Market Access and Drug Safety Act of 2009.
Client expense: — · Firm income: $60,000
Matched citations: S.525
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · first_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate. S.525, The Pharmaceutical Market Access and Drug Safety Act of 2009.
Client expense: — · Firm income: $60,000
Matched citations: S.525
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · first_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate. Tax policy (repatriation). S.525, The Pharmaceutical Market Access and Drug Safety Act of 2009.
Client expense: — · Firm income: $60,000
Matched citations: S.525
Pharmaceutical Market Access and Drug Safety Act of 2009
2009 · first_quarter · Firm: MEHLMAN CONSULTING, INC.
Health reform and related health care issues, including potential changes to Medicaid rebate. S.525, The Pharmaceutical Market Access and Drug Safety Act of 2009.
Client expense: — · Firm income: $60,000
Matched citations: S.525
Medicare Improvements for Patients and Providers Act of 2008
2008 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
S.3101 and H.R. 6331, the Medicare Improvements for Patients and Providers Act of 2008 (6 protected classes provisions).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6331
Medicare Improvements for Patients and Providers Act of 2008
2008 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
S.3101 and H.R. 6331, the Medicare Improvements for Patients and Providers act of 2008 (6 protected classes provisions).
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6331
Medicare Improvements for Patients and Providers Act of 2008
2008 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
S.3101 and H.R. 6331, the Medicare Improvements for Patients and Providers Act of 2008 (6 protected classes provisions).
Client expense: — · Firm income: $60,000
Matched citations: S.3101
Medicare Improvements for Patients and Providers Act of 2008
2008 · second_quarter · Firm: MEHLMAN CONSULTING, INC.
S.3101 and H.R. 6331, the Medicare Improvements for Patients and Providers act of 2008 (6 protected classes provisions).
Client expense: — · Firm income: $60,000
Matched citations: S.3101
Medicare Improvements for Patients and Providers Act of 2008
2008 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
S.3101 and H.R.6331, the Medicare Improvements for Patients and Providers Act of 2008 (six protected classes provisions).
Client expense: — · Firm income: $60,000
Matched citations: H.R.6331
Source: Senate LDA